DSGN (Design Therapeutics, Inc.) Company Short-Term Debts

Corporate company logo of Design Pharma (DSGN)

The Design Therapeutics (DSGN) price chart demonstrates the asset's dynamics, with a metric of 0.00. The business relies on robotic complexes for 24/7 biomolecule analysis, which accelerates drug discovery. Design Therapeutics (DSGN) develops small molecules for the therapy of hereditary pathologies, utilizing GeneTAC to correct gene expression without editing, specifically for Friedreich's ataxia.

DSGN designtx.com Short-Term Debt Volume (07/04/2022 - 10/30/2026)

Analytical breakdowns for Design Therapeutics

- stock price and consensus target price:
Stock Price Design Therapeutics, Inc.|DSGN - Broker Consensus Forecast
- business market valuation indicators:
Market Capitalization Design Therapeutics, Inc.|DSGN - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Design Therapeutics|DSGN - Book Valuation of Business|Market Capitalization to Book Value Ratio designtx.com|DSGN - Company Total Asset Base
- debt and liquidity details:
Total Debt to Capital Design Therapeutics|DSGN - Long-Term Indebtedness to Equity|Short-Term Debt to Equity Design Therapeutics|DSGN - Company Aggregate Debt|Debt to Book Value Design Therapeutics, Inc.|DSGN - Company Long-Term Loans and Borrowings|Company Current Liabilities Design Therapeutics|Quick Ratio designtx.com
- earnings and multiples data:
DSGN - Final Profit
Fundamental valuation:Design Therapeutics, Inc. - DSGN
Manufactured products of Design Therapeutics

Design Therapeutics develops gene-targeted therapies for the treatment of rare hereditary DNA pathologies. By analyzing the size of short-term liabilities, an investor assesses the volume of obligations maturing within one year. This metric measures liquidity and the company's ability to service operational loans without raising emergency capital. For a startup in an embryonic sector, this is a critical marker of financial stability prior to commercialization. The consensus suggests monitoring debt to eliminate default risks.

Competing companies

Tempus AI, Inc - Company Short-Term Debts|QGEN (Qiagen NV) - Company Short-Term Indebtedness|IONS: Company Short-Term Debts|Short-Term Debt Repligen Inc. (RGEN)|Company Short-Term Debt Avidity Biosciences|crisprtx.com (CRSP) - Short-Term Debt Volume|Company Short-Term Debts WGS|Short-Term Debt Volume Ultragenyx Pharmaceutical Inc.|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Short-Term Indebtedness Sarepta Corp|TWST - Company Short-Term Debt|TXG (10xgenomics.com) - Company Short-Term Indebtedness|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|Stoke Therapeutics Inc - Company Short-Term Loans and Borrowings|Company Current Liabilities BLFS|WVE (Wave Pharma) - Amount of Current Liabilities|Company Short-Term Debts MAZE|SION (sionnatx.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts PRME (Prime Medicine)|Taysha Gene Therapies Inc (TSHA) - Short-Term Debt|QURE - Company Short-Term Debt|Company Short-Term Loans and Borrowings MGTX (MeiraGTx Corp)|RGNX: Company Short-Term Debts|solidbio.com (SLDB) - Company Short-Term Debts|Company Short-Term Debt Ocugen|Pacific Biosciences of California, Inc. - Current Liabilities|Company Short-Term Debts BNTC|RCKT - Short-Term Debt|4D Molecular Therapeutics - Company Current Liabilities|Company Short-Term Debts Lexeo Therapeutics Inc. LXEO|KRRO: Company Current Liabilities|Editas Medicine Inc - Amount of Current Liabilities|SLN: Company Short-Term Debts|PRQR - Short-Term Debt Volume|CDXS (Codexis Inc) - Company Short-Term Debts|Company Current Liabilities sangamo.com (SGMO)|Company Short-Term Debt Nautilus Biotechnology (NAUT)|Short-Term Debt Volume Metagenomi Inc.|Company Short-Term Debts DTIL (Precision BioSciences)|GBIO: Company Short-Term Indebtedness|BOLD - Company Short-Term Debt|Short-Term Debt Volume Exicure, Inc. XCUR|IMNN: Company Short-Term Debts|Short-Term Indebtedness Phio Pharmaceuticals Corp. PHIO|Company Short-Term Debt Mustang Bio Inc|Company Short-Term Indebtedness RNAZ (TransCode)|Company Short-Term Debts BNGO|adnas.com - Company Short-Term Indebtedness|Company Short-Term Debt bluebird bio BLUE|IPA: Company Short-Term Indebtedness|Omega - Company Short-Term Debts|OMIC - Company Short-Term Debts|RGLS: Company Short-Term Debts|Company Short-Term Indebtedness SYRS|TBIO (Telesis Bio) - Company Short-Term Debts|Short-Term Debt TRACON Pharmaceuticals Inc. TCON|Company Short-Term Debt Unity Bio (UBX)